trial

Measuring Time Windows in Patients With Schizophrenia and Healthy Controls

NCTId NCT00350805
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 126 (actual)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2012-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
126 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2005-09
Primary completion
2012-04
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
EEG

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
Centre National de la Recherche Scientifique, FranceCollaborator
Institut de Physique Biologique de StrasbourgCollaborator

Investigators

1
Anne GIERSCH, MD, PhDPrincipal Investigator

Sites

3 total
Créteil, FranceRouffach, FranceStrasbourg, France

Facts & assertions

4 sourced
Enrollment
126
Phase
NA
Primary Completion Date
2012-04
Status
COMPLETED
relationships
The graph out of here
drug
EEG
drug
lead_sponsor
University Hospital, Strasbourg, France
company
collaborator
Institut National de la Santé Et de la Recherche Médicale, France
company
Centre National de la Recherche Scientifique, France
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Anne GIERSCH, MD, PhD
person